Page 2 - Remunity Pump News Today

Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) traded up 5% during mid-day trading on Wednesday following a better than expected earnings announcement. The company traded as high as $227.75 and last traded at $224.90. 84,811 shares traded hands during trading, a decline of 74% from the average session volume of 324,358 shares. […]

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) was up 5% during trading on Wednesday after the company announced better than expected quarterly earnings. The company traded as high as $227.75 and last traded at $224.90. Approximately 84,811 shares were traded during mid-day trading, a decline of 74% from the average daily volume of 324,358 […]

True Wealth Design LLC grew its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 335,800.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,359 shares of the biotechnology company’s stock after purchasing an additional 3,358 shares during the quarter. True […]

True Wealth Design LLC raised its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 335,800.0% during the third quarter, HoldingsChannel reports. The firm owned 3,359 shares of the biotechnology company’s stock after purchasing an additional 3,358 shares during the period. True Wealth Design LLC’s holdings in United Therapeutics were worth $759,000 […]

True Wealth Design LLC grew its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 335,800.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,359 shares of the biotechnology company’s stock after purchasing an additional 3,358 shares during the quarter. True […]

Brandes Investment Partners LP increased its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 4.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,209 shares of the biotechnology company’s stock after buying an additional 689 shares during the quarter. Brandes […]

Brandes Investment Partners LP lifted its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 4.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,209 shares of the biotechnology company’s stock after buying an additional 689 shares […]

StockNews.com cut shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a strong-buy rating to a buy rating in a report published on Wednesday. Other equities analysts have also issued reports about the stock. JPMorgan Chase & Co. boosted their target price on shares of United Therapeutics from $290.00 to $294.00 and gave the company […]

The Goldman Sachs Group upgraded shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a sell rating to a neutral rating in a research report sent to investors on Monday morning, MarketBeat reports. The firm currently has $215.00 target price on the biotechnology company’s stock, up from their prior target price of $213.00. UTHR has […]

The Goldman Sachs Group upgraded shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a sell rating to a neutral rating in a research report released on Monday, MarketBeat reports. The Goldman Sachs Group currently has $215.00 price target on the biotechnology company’s stock, up from their prior price target of $213.00. Other equities analysts […]